Peptides for Skin
Last reviewed
Copper peptides and other peptide creams are some of the most popular "active" skincare ingredients. Here's what the human studies actually tested, how strong that evidence is, and how these products are regulated.
The short version
- Copper peptides (GHK-Cu) and palmitoyl pentapeptide-4 (Matrixyl) are the best-studied skincare peptides. Both have small human trials showing improvements in wrinkles and skin quality over about 12 weeks.
- The trials are small, and some were run or funded by the companies that make the ingredients.
- Skincare peptides are cosmetics: the FDA doesn't approve them before they're sold.
Copper peptides (GHK-Cu)
GHK-Cu is a tripeptide (glycine, histidine, lysine) bound to copper, and it occurs naturally in human plasma. On ingredient lists it often appears as copper tripeptide-1.
A 2018 review by researchers who have studied it for decades summarizes the human skin studies:
- A GHK-Cu facial cream used for 12 weeks by 71 women improved skin density, thickness, firmness, clarity and wrinkles.
- A GHK-Cu eye cream used for 12 weeks by 41 women with sun damage did better than both placebo and a vitamin K cream.
- GHK-Cu applied to thigh skin for 12 weeks increased collagen in 70% of the women treated, compared with vitamin C cream and retinoic acid.
- In a randomized, double-blind trial, GHK-Cu in a nano-lipid carrier, used twice a day for 8 weeks, reduced wrinkle volume compared with a control serum.
Much of the rest of the research is in cells and animals, for example GHK-Cu increasing collagen and elastin production in human skin cells grown in a lab, and wound-healing studies in mice, rats and pigs.
How strong is it? Promising, but limited: the human studies are small, short, and mostly from the same research group. There are no large independent trials.
Palmitoyl pentapeptide-4 (Matrixyl)
Palmitoyl pentapeptide-4, sold under the name Matrixyl, was designed to stimulate collagen. Its best-known trial, published in 2005, gave 93 women aged 35 to 55 a moisturizer with the peptide on one side of the face and the same moisturizer without it on the other, for 12 weeks. The peptide side showed significantly greater improvement in wrinkles and fine lines, and it was well tolerated. The study was supported by the company that developed the ingredient.
Other skincare peptides
A 2017 review of topical peptides notes that some have been proven effective in clinical skin trials, with palmitoyl pentapeptide-4 among the best researched. Others, like acetyl hexapeptide-8 (Argireline), are often marketed as "Botox in a jar," but there's far less published human evidence behind that comparison.
Cosmetic or drug? Why the wording matters
Skincare peptides are sold as cosmetics, and cosmetics and their ingredients (other than color additives) don't need FDA approval before they're sold. Under the law, though, whether a product is a cosmetic or a drug depends on its intended use: a product marketed to change the body's structure or treat a condition can be a drug. That's why most peptide creams promise to improve the appearance of wrinkles rather than to "rebuild collagen."
Topical vs. injectable GHK-Cu
Everything above is about creams and serums. Injectable GHK-Cu is a different product with a different status: the FDA took it off its compounding "significant safety concerns" list in 2026, with an advisory committee review expected before February 2027. See the FDA status tracker and our GHK-Cu reconstitution calculator.
Frequently asked questions
Do copper peptides work for skin?
Small human studies of GHK-Cu creams, most running 12 weeks, reported improvements in skin thickness, firmness and fine wrinkles. The studies are small and several come from one research group, so the evidence is promising but limited.
What is GHK-Cu?
A copper-binding tripeptide (glycine, histidine, lysine) that occurs naturally in human plasma. In skincare it's often called copper peptide or copper tripeptide-1.
Are skincare peptides FDA-approved?
No. Cosmetics and their ingredients, other than color additives, don't need FDA approval before they're sold.
What's the best-studied skincare peptide?
Palmitoyl pentapeptide-4 (Matrixyl) and GHK-Cu have the most published human research, though both rest on small trials.
Sources
- Pickart and Margolina, Regenerative and protective actions of the GHK-Cu peptide, International Journal of Molecular Sciences (2018)
- Robinson et al., Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin, International Journal of Cosmetic Science (2005)
- Schagen, Topical peptide treatments with effective anti-aging results, Cosmetics (2017)
- FDA: Authority over cosmetics
- FDA: Is it a cosmetic, a drug, or both?
- Goodwin: FDA's 2026 peptide compounding changes